Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00814281 · ClinicalTrials.gov registry record · NA
Airborne Ultrafine and Fine Particulate Matter: A Cause for Endothelial Dysfunction in Man?
A NA study, sponsored by Marywood University.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT00814281: Completed NA study, sponsored by Marywood University.
NCT00814281 is a NA study that has completed, run by Marywood University. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00814281, a NA study, has completed, sponsored by Marywood University.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to examine biological pathways of altered blood vessel function resulting from breathing airborne particulate. Blood artery function in healthy men will be measured after particulate exposure either on placebo or on an asthma medication that stops production of an inflammatory biological agent. Lung and blood profiles will be obtained before and after exposure to exhaust fumes. We believe that the inflammatory agent produced by the lungs from breathing these particles causes abnormal artery function.
Interventions
- DRUG Montelukast
- OTHER placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2007-05 |
| Est. Completion | 2009-05 |
| Phase | NA |
What the finished NCT00814281 record still lists
NCT00814281 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Montelukast is the first listed.
NCT00814281 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00814281 about?
NCT00814281 is a clinical study titled "Airborne Ultrafine and Fine Particulate Matter: A Cause for Endothelial Dysfunction in Man?". The purpose of this study is to examine biological pathways of altered blood vessel function resulting from breathing airborne particulate. Blood artery function in healthy men will be measured after particulate exposure either on placebo or on an asthma medication that stops production of an inflam...
What is the current status of trial NCT00814281?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2007-05. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00814281?
The interventions under investigation include: Montelukast (DRUG), placebo (OTHER).
Who is sponsoring clinical trial NCT00814281?
This trial is sponsored by Marywood University, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00814281's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia